Myoblasts derived from mouse skeletal muscle (cat. no. CRL-1772; American Type Culture Collection) were cultured in 6-well plates containing Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc.) supplemented with 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.), 100 U/ml penicillin, and 100 µg/ml streptomycin (Gibco; Thermo Fisher Scientific, Inc.) at 37°C in a humidified atmosphere of 5% CO2. When myoblasts were approximately 80–90% confluent, myotube differentiation was initiated by replacing the growth medium with differentiation medium: DMEM supplemented with 2% FBS. Differentiation was allowed to proceed for 6 days, with the medium changed every 48 h, at which stage 90–100% of the cells had fused into myotubes.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.